BridgeMD
New treatment option for Breast Cancer
Official title Radiofrequency and Exercise-based Rehabilitation on Symptoms Associated With Pelvic Floor Dysfunctions in Breast Cancer
ClinicalTrials.gov ID: NCT06694519
What this study is testing
- What it's testing
- Breast cancer has a high impact, affecting 2.3 million women worldwide in 2022. In Spain, there were 40,203 new cases in 2023.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only
You may be able to join if
- women of legal age with a clinical history of breast cancer, who agree to participate in the study and who present pelvic dysfunction assessed by the...
- women survivors of stage 1 and 2 breast cancer
- A medical discharge was granted more than one year ago
- A diagnosis of another type of cancer has not been made.
You likely can't join if
- Having performed PMFT or received RF in the last 12 months
- Use of vaginal oestrogens in the last 6 months
- Systemic hormone therapy in the last 6 months
- Laser therapy in the last 6 months
- Absence of pelvic floor contraction according to the Modified Oxford Scale
- Use of pacemaker
See the full eligibility criteria
- women of legal age with a clinical history of breast cancer, who agree to participate in the study and who present pelvic dysfunction assessed by the Pelvic Floor Distress Inventory (PFDI20) ≥ 100
- women survivors of stage 1 and 2 breast cancer
- A medical discharge was granted more than one year ago
- A diagnosis of another type of cancer has not been made.
- Having performed PMFT or received RF in the last 12 months
- Use of vaginal oestrogens in the last 6 months
- Systemic hormone therapy in the last 6 months
- Laser therapy in the last 6 months
- Absence of pelvic floor contraction according to the Modified Oxford Scale
- Use of pacemaker
- Use of heart pacemaker, decompensated heart or metabolic diseases, cognitive deficits, peripheral or central neurological disorders, previous surgeries in the pelvic region, skin pathologies or wounds in the treatment...
The study team makes the final eligibility decision.
Where it's taking place
- Elche, Spain / Valencia, Spain
Compensation & support
A stipend or compensation may be offered.
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Elche, Spain / Valencia, Spain. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.